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Hypereosinophilic syndrome (HES) is a multisystem disorder 
diagnosed by the presence of hypereosinophilia (HE) defined as 
an absolute eosinophil count (AEC) >1.5x109/L (or >1500cells/
microL) and multi organ involvement attributable to HE. Myocardial 
dysfunction is a frequent finding and is a major cause of morbidity 
and mortality in HES. The diagnosis of hypereosinophilic heart 
disease (EHD) is made in the setting of hypereosinophilia and 
characteristic clinical features and imaging findings of damage to 
the heart. We describe those clinical features in this case of HES with 
HHD with review of literature. 
A 63 year old active smoker male with no known past medical history 
was transferred to our hospital for hypotension, abnormal EKG and 
elevated troponin. The patient described nonspecific symptoms of 
cough, runny nose, malaise, muscle aches, nausea, diarrhea and 
low grade fever for 2-3 weeks. He also noted a skin rash which had 
resolved at the time of admission. He denied air travel outside the 
United States.
His examination revealed diminished lung sounds bilaterally, normal 
heart sounds with a soft 1/6 intensity holosystolic murmur without 
marked radiation of the murmur. There was mild lower extremity 
edema present.
DISCUSSION
HES are a heterogeneous group of disorders. Typically symptoms are very 
nonspecific as in our case. A rash, GI disturbances, cough and dyspnea are 
the common symptoms. Pathophysiology of EHD includes three overlapping 
stages: 1) an acute necrosis, 2) thrombosis and 3) fibrosis. The clinical 
presentation of EHD is variable and may range from an asymptomatic 
myocardial involvement to heart failure syndrome, conduction abnormality, 
fatal arrhythmia, sudden cardiac death or an acute coronary like syndrome. 
It is important to note that EHD can be seen in any cause of eosinophilia or 
hypereosinophilia such as drugs and hypersensitivity reactions, parasitic or 
protozoal infections, malignancies, idiopathic hypereosinophilic syndromes 
or vasculitis syndromes.
Endomyocardial biopsy is the reference standard test for the definite 
diagnosis of EHD. Eosinophilia is present in the majority of the patients. 
Electrocardiographic changes are common but nonspecific and may 
include criteria for left ventricular hypertrophy, arrhythmias or AV block.
CONCLUSIONS
Echocardiography plays a vital role in suspecting and identifying EHD. 
Cardiac MRI has higher sensitivity and specificity than any other imaging 
modalities. It is important to find the etiology of hypereosinophila and treat 
it accordingly. Offending drug needs to be discontinued.
Malignancies and Vasculitis treated accordingly. Steroids have remained 
the mainstay of therapy in acute settings LAB DATA AND IMAGING
Laboratory data revealed hyponatremia, normal creatinine and an 
elevated troponin I value of 2.89, WBC count of 15000, Hb of 9 gram/
dl and platelet count of 40,000. His eosinophil count was 4800 
(UNITS), LDH 719, 32% Eos.
CT contrast chest abdomen and pelvis revealed no PE or dissection, 
marked lymphadenopathy and small pleural effusions only.
His EKG  was sinus rhythm with diffuse T wave inversions.
Transthoracic echocardiogram revealed hyperdynamic left ventricular 
(LV) systolic function and apical thickening concerning for an LV 
thrombus (Figure 1a & 1b).
MRI of the heart confirmed the diagnosis of apical thrombus along 
with fibrotic material seen in both LV and RV apex (Figure 2a & 2b).
IMAGES
His axillary lymph node biopsy showed angio-
immunoblastic T cell lymphoma.  He was readmitted 
again for VT and chemotherapy induced pancytopenia. 
Required high doses of steroids while inpatient. 
His Eosinophil count on discharge was 0% compared 
to 32% maximum on first admission.
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